The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To examine the relationship between glycated haemoglobin A1c (HbA1c) levels and the risk of cardiovascular outcomes and all-cause mortality based on data from observational studies and to determine the optimal levels of HbA1c for preventing cardiovascular events and/or mortality in diabetic and non-diabetic populations. REVIEW METHODS: We systematically searched Medline, Embase, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews and Web of Science databases, from inception to July 2016, for observational studies addressing the association of HbA1c levels with mortality and cardiovascular outcomes. Random effects models were used to compute pooled estimates of HR and respective 95% CI for all-cause mortality, cardiovascular mortality and risk of cardiovascular events, separately for people with and without diabetes. RESULTS: Seventy-four published studies were included in the systematic review, but only 46 studies could be incorporated in the meta-analysis. In both diabetic and non-diabetic populations, there was an increase in the risk of all-cause mortality when HbA1c levels were over 8.0% and 6.0%, respectively. The highest all-cause mortality in people with diabetes was HbA1c above 9.0% (HR=1.69; 95% CI 1.09 to 2.66) and in those without diabetes was HbA1c above 6.0% (HR=1.74; 95% CI 1.38 to 2.20). However, both diabetic and non-diabetic populations with lower HbA1c levels (below 6.0% HR=1.57; 95% CI 1.14 to 2.17 and below 5.0% HR=1.19; 95% CI 1.04 to 1.36, respectively) had higher all-cause mortality. Similar pooled estimates were found when cardiovascular mortality was the outcome variable. CONCLUSION: HbA1c is a reliable risk factor of all-cause and cardiovascular mortality in both diabetics and non-diabetics. Our findings establish optimal HbA1c levels, for the lowest all-cause and cardiovascular mortality, ranging from 6.0% to 8.0% in people with diabetes and from 5.0% to 6.0% in those without diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“analyses of the fidelity of DM diagnosis using A1C have reported a lower sensitivity than FPG or 2-hour OGTT.4,5,7-10”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [7]
Experimental — accuracy not yet measuredIn the citing paper
“A meta-analysis of 46 observational studies reported that patients with diabetes with HbA1c ranging from 6.0% to 8.0% had the lowest all-cause and CVD mortality (27).”
From Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study (2021) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,586
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
The file drawer problem and tolerance for null results.
Rosenthal, R. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.3.638 · Cited by 9,068
Research works printed but not linked: 3
- 10.1037//0033-2909.86.3.638 · DOI · Paper page
- 10.2337/diacare.20.7.1183 · DOI · Paper page
- 10.2337/dc15-S005 · DOI · Paper page
Cited by
Sorted by citations
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk
Chia, C. W., Egan, J. M., & Ferrucci, L. (2018) · Circulation Research · doi:10.1161/circresaha.118.312806 · Cited by 454
Quagliariello, V., Laurentiis, M. D., Rea, D., Barbieri, A., Monti, M. G., Carbone, A., Paccone, A., Altucci, L., Conte, M., Canale, M. L., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01346-y · Cited by 371
Lu, J., Wang, C., Shen, Y., Chen, L., Zhang, L., Cai, J., Lu, W., Zhu, W., Hu, G., Xia, T., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1862 · Cited by 282
Beverly, J., & Budoff, M. J. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12970 · Cited by 219
The oral microbiome in the pathophysiology of cardiovascular disease
Tonelli, A., Lumngwena, E. N., & Ntusi, N. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00825-3 · Cited by 184
Ye, X., Kong, W., Zafar, M. I., & Chen, L.-L. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0851-z · Cited by 138
Su, W., Chen, S., Huang, Y.-T., Huang, J., Wu, P.-Y., Hsu, W., & Lee, M. (2019) · Nutrients · doi:10.3390/nu11112838 · Cited by 113
Unraveling female reproductive senescence to enhance healthy longevity
Dong, L., Teh, D. B. L., Kennedy, B. K., & Huang, Z. (2023) · Cell Research · doi:10.1038/s41422-022-00718-7 · Cited by 101
Hypomagnesemia and Cardiovascular Risk in Type 2 Diabetes
Oost, L. J., Tack, C. J., & de Baaij, J. H. F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac028 · Cited by 78
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
Martínez‐Arranz, I., Bruzzone, C., Noureddin, M., Gil‐Redondo, R., Mincholé, I., Bizkarguenaga, M., Arretxe, E., Iruarrizaga‐Lejarreta, M., Fernández‐Ramos, D., Lopitz‐Otsoa, F., et al. (2022) · Hepatology · doi:10.1002/hep.32427 · Cited by 65
Lingvay, I., Deanfield, J. E., Kahn, S. E., Weeke, P. E., Toplak, H., Scirica, B. M., Rydén, L., Rathor, N., Plutzky, J., Morales, C., et al. (2024) · Diabetes Care · doi:10.2337/dc24-0764 · Cited by 72
Dawson, A. Z., Walker, R. J., Campbell, J. A., Davidson, T. M., & Egede, L. E. (2020) · mHealth · doi:10.21037/mhealth.2019.12.03 · Cited by 63
Goh, L. H., Siah, C. J. R., Tam, W., Tai, E. S., & Young, D. Y. L. (2022) · Systematic Reviews · doi:10.1186/s13643-022-02117-w · Cited by 74
Diabetes and cognitive decline
Bellia, C., Lombardo, M., Meloni, M., Della‐Morte, D., Bellia, A., & Lauro, D. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.07.006 · Cited by 59
Döbler, A., Belnap, B. H., Pollmann, H., Farin‐Glattacker, E., Raspe, H. H., & Mittag, O. (2018) · Rehabilitation Psychology · doi:10.1037/rep0000224 · Cited by 58
Diabetes, Glycemic Control, and Risk of Infection Morbidity and Mortality: A Cohort Study
Chang, C.-H., Wang, J.-L., Wu, L.-C., Chuang, L.-M., & Lin, H.-H. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz358 · Cited by 54
Hemoglobin A1c—Using Epidemiology to Guide Medical Practice: Kelly West Award Lecture 2020
Selvin, E. (2021) · Diabetes Care · doi:10.2337/dci21-0035 · Cited by 57
Alharthi, S. K., Alyusuf, E. Y., Alguwaihes, A. M., Alfadda, A. A., & Al‐Sofiani, M. E. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108682 · Cited by 53
Fan, H., Huang, Y., Zhang, H., Feng, X., Yuan, Z., & Zhou, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.846659 · Cited by 51
Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
Ahmad, E., Sargeant, J. A., Zaccardi, F., Khunti, K., Webb, D. R., & Davies, M. J. (2020) · Pharmaceuticals · doi:10.3390/ph13120427 · Cited by 54
de Kreutzenberg, S. V. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00524-7 · Cited by 48
Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.02.002 · Cited by 60
Cuadrado‐Godia, E., Jamthikar, A. D., Gupta, D., Khanna, N. N., Araki, T., Maniruzzaman, M., Saba, L., Nicolaides, A. N., Sharma, A., Omerzu, T., et al. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.03.020 · Cited by 41
Metabolic Syndrome Including Glycated Hemoglobin A1c in Adults: Is It Time to Change?
Cavero‐Redondo, I., Martínez‐Vizcaíno, V., Álvarez‐Bueno, C., Agudo‐Conde, C., Lugones‐Sánchez, C., & García‐Ortiz, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122090 · Cited by 39
Hambling, C. E., Khunti, K., Cos, X., Wens, J., Martinez, L., Topsever, P., Prato, S. D., Sinclair, A. J., Schernthaner, G., Rutten, G. E. H. M., et al. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2018.12.005 · Cited by 38
Srour, B., Kaaks, R., Johnson, T., Hynes, L. C., Kuhn, T. E., & Katzke, V. A. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00828-3 · Cited by 34
Lu, J., Wang, C., Cai, J., Shen, Y., Chen, L., Zhang, L., Lu, W., Zhu, W., Hu, G., Xia, T., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab532 · Cited by 33
MacKay, D., Chan, C. B., Dasgupta, K., Dominy, C., Gagner, M., Jin, S., Kim, J., Little, J. P., MacDonald, B., McInnes, N., et al. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.10.004 · Cited by 39
Turton, J. L., Brinkworth, G. D., Parker, H. M., Lim, D. M., Lee, K., Rush, A., Johnson, R., & Rooney, K. B. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288440 · Cited by 36
Lumu, W., Bahendeka, S., Wesonga, R., Kibirige, D., Mutebi, R. K., & Ssendikwanawa, E. (2023) · African Health Sciences · doi:10.4314/ahs.v23i1.54 · Cited by 33
Cavero‐Redondo, I., Peleteiro, B., Álvarez‐Bueno, C., Artero, E. G., Garrido‐Miguel, M., & Martínez‐Vizcaíno, V. (2018) · Sports Medicine · doi:10.1007/s40279-018-0861-0 · Cited by 34
Mitro, S. D., Sagiv, S. K., Fleisch, A. F., Jaacks, L. M., Williams, P. L., Rifas‐Shiman, S. L., Calafat, A. M., Hivert, M., Oken, E., & James-Todd, T. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa431 · Cited by 31
Association of hemoglobin A1c with the incidence of hypertension: A large prospective study
Huang, X. S., Qin, C., Guo, X., Cao, F., & Tang, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1098012 · Cited by 31
Salamah, H. M., Marey, A., Abugdida, M., Abualkhair, K. A., Elshenawy, S., Elhassan, W. A. F., Naguib, M. M., Malnev, D., Durrani, J., Bailey, R., et al. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01371-3 · Cited by 36
Rozing, M. P., Møller, A., Aabenhus, R. M., Siersma, V., Rasmussen, K. V., & Køster‐Rasmussen, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225230 · Cited by 28
Butalia, S., Chu, L. M., Dover, D. C., Lau, D., Yeung, R. O., Eurich, D. T., Senior, P. A., & Kaul, P. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.031095 · Cited by 33
Community Health Workers as Trust Builders and Healers: A Cohort Study in Primary Care
Ferrer, R. L., Schlenker, C. G., Cruz, I. I., Noël, P. H., Palmer, R. F., Poursani, R. S., & Jaén, C. R. (2022) · The Annals of Family Medicine · doi:10.1370/afm.2848 · Cited by 33
Shemesh, S. S., Sidon, E., Kaisler, E., Sheinis, D., Velkes, S., Ohana, N., & Benayahu, D. (2017) · European Spine Journal · doi:10.1007/s00586-017-5315-0 · Cited by 28
Saisho, Y. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1776262 · Cited by 28
Macêna, M. D. L., Nunes, L. F. D. S., da Silva, A. F., Pureza, I. R. D. O. M., Praxedes, D. R. S., Santos, J. C. D. F., & Bueno, N. B. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac035 · Cited by 29
Schweiger, D. Š., Battelino, T., & Grošelj, U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910192 · Cited by 27
Cincione, R. I., Messina, A., Cibelli, G., Messina, G., Polito, R., Losavio, F., Torre, M. E. L., Monda, V., Monda, M., Quiete, S., et al. (2022) · Nutrients · doi:10.3390/nu14204361 · Cited by 34
Moody, E. C., Cantoral, A., Tamayo-Ortiz, M., Pizano-Zárate, M. L., Schnaas, L., Kloog, I., Oken, E., Coull, B., Baccarelli, A., Téllez-Rojo, M. M., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17643 · Cited by 27
Prognostic Markers in Advanced Heart Failure
Godhiwala, P., Acharya, S., Kumar, S., & Bagga, C. S. (2021) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2021/8 · Cited by 27
Botoseneanu, A., Markwardt, S., & Quiñones, A. R. (2023) · Gerontology · doi:10.1159/000528648 · Cited by 25
Diabetes, dysglycemia, and vascular surgery
Duwayri, Y. M., & Jordan, W. D. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.05.027 · Cited by 27
Mihara, A., Ohara, T., Hata, J., Honda, T., Chen, S., Sakata, S., Oishi, E., Hirakawa, Y., Nakao, T., Kitazono, T., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.016 · Cited by 25
Khunti, K. K., & Aroda, V. R. (2022) · Diabetes Care · doi:10.2337/dci21-0064 · Cited by 24
Currenti, W., Losavio, F., Quiete, S., Alanazi, A. M., Messina, G., Polito, R., Ciolli, F., Zappalà, R. S., Galvano, F., & Cincione, R. I. (2023) · Nutrients · doi:10.3390/nu16010095 · Cited by 23
dos Reis, R. C. P., Duncan, B. B., Szwarcwald, C. L., Malta, D. C., & Schmidt, M. I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153428 · Cited by 24
Yu, X., Chen, C., Guo, Y. C., Tong, Y., Zhao, Y., Wu, L., Sun, X., Wu, X., & Song, Z. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1974081 · Cited by 23
Frank, J., Blissett, D. B., Hellmund, R., & Virdi, N. S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0263 · Cited by 27
Ahmed, Z., Zeeshan, S., & Liang, B. T. (2021) · Human Genomics · doi:10.1186/s40246-021-00367-8 · Cited by 23
Alghamdi, S., Bieber, B. A., Alrukhaimi, M. N., AlSahow, A., Salmi, I. A., Ali, F. A., Aradi, A. H. A., Pecoits-Filho, R., Robinson, B. M., Pisoni, R. L., et al. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.02.012 · Cited by 23
Bielska, A., Bauer, W., Szałkowska, A., Sidorkiewicz, I., Skwarska, A., Raczkowska, J., Ostrowski, D., Gugała, K., Dobrzycki, S., Niemira, M., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.888948 · Cited by 22
Luo, S., Yeung, S. L. A., & Schooling, C. M. (2021) · Diabetologia · doi:10.1007/s00125-021-05537-w · Cited by 23
Zhao, H., Liu, M., Chen, Z., Mei, K., Yu, P., & Xie, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227262 · Cited by 22
Glycated Hemoglobin and Risk of Arterial Stiffness in a Chinese Han Population: A Longitudinal Study
Han, Z., Kang, X., Zhang, J., Wang, J., Liu, Y., Liu, J., Wu, Z., Li, X., Zhao, X., Guo, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.854875 · Cited by 21
Chin, K. L., Ofori-Asenso, R., Si, S., Hird, T. R., Magliano, D. J., Zoungas, S., & Liew, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-40191-8 · Cited by 23
Evans, M., Chandramouli, A. S., Faurby, M. D., Matthiessen, K. S., Mogensen, P. B., & Verma, S. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14703 · Cited by 20
Shiferaw, W. S., Akalu, T. Y., Desta, M., Kassie, A. M., Petrucka, P. M., Assefa, H. K., & Aynalem, Y. A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.10.003 · Cited by 25
Kostov, K. G., & Blazhev, A. B. (2020) · Medicina · doi:10.3390/medicina56050231 · Cited by 22
Higher dementia incidence in older adults with type 2 diabetes and large reduction in HbA1c
Lee, A. T. C., Richards, M., Chan, W. C., Chiu, H. F. K., Lee, R. S. Y., & LAM, L. C. W. (2019) · Age and Ageing · doi:10.1093/ageing/afz108 · Cited by 20
Remission of Type 2 Diabetes: User’s Guide
Jin, S., BAJAJ, H. S., Brazeau, A., Champagne, J., MacDonald, B., MacKay, D., Reichert, S. M., Vallis, M., BAJAJ, H. S., Gilbert, J. D., et al. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.10.005 · Cited by 19
Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-Analysis
Shah, R. H., Vedantam, S., Kumar, S., Amin, S., Pearlman, M. Y., & Bhalla, S. (2023) · Obesity Surgery · doi:10.1007/s11695-022-06437-7 · Cited by 17
A perspective on treating type 1 diabetes mellitus before insulin is needed
Tatović, D., Narendran, P., & Dayan, C. M. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00816-5 · Cited by 22
Sari, M. I., Tala, Z. Z., & Wahyuni, D. D. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.168 · Cited by 17
Role and Risk Factors of Glycosylated Hemoglobin Levels in Early Disease Screening
Chao, G., Zhu, Y., & Chen, L. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6626587 · Cited by 16
Darwish, L., Nguyen, M., Saleem, M., Eakin, K. A., Herrmann, N., Sugamori, K. S., OH, P. I., Yang, P., Mitchell, J., Lanctôt, K. L., et al. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.01.003 · Cited by 19
Liu, L., Ye, J., Ying, M., Li, Q., Chen, S., Wang, B., Lin, Y., Chen, G., Lun, Z., Huang, H., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.632704 · Cited by 16
Liu, L., Zhen, D., Fu, S., Sun, W.-M., Li, H., Zhao, N., Hou, L., & Tang, X. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00827-8 · Cited by 15
Cavero‐Redondo, I., Saz‐Lara, A., Martínez‐García, I., Otero-Luis, I., & Martínez‐Rodrigo, A. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02104-y · Cited by 17
Lou, Y., Li, P. H., Liu, X. Q., Wang, T. X., Liu, Y. L., Chen, C. C., & Ma, K. L. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03505-1 · Cited by 14
Significant association between blood lead (Pb) level and haemoglobin A1c in non-diabetic population
Chang, C., Wang, C., Wu, D., Lee, W.-H., Chen, Y., Liu, Y., Li, C.-H., Tsai, C., Lin, W., Chen, S., et al. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101233 · Cited by 15
Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?
Eckel, R. H., Farooki, A., Henry, R. R., Koch, G. G., & Leiter, L. A. (2019) · Clinical Diabetes · doi:10.2337/cd19-0001 · Cited by 15
A scoping review of polypharmacy interventions in patients with stroke, heart disease and diabetes
Lum, M. V., Cheung, M. Y. S., Harris, D. R., & Sakakibara, B. M. (2020) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-020-01028-x · Cited by 15
The growing use of continuous glucose monitors in people without diabetes: an evidence‐free zone
Guess, N. D. (2023) · Practical Diabetes · doi:10.1002/pdi.2475 · Cited by 16
Wang, W., Hsu, P., Lin, C.-C., Wang, Y., Ding, Y.-Z., Liou, T., Wang, Y.-W., Huang, S., Lu, T., Huang, P., et al. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.51425 · Cited by 13
Heald, A. H., Stedman, M., Robinson, A., Davies, M., Livingston, M. A., Alshames, R., Moreno, G., Gadsby, R., Rayman, G. A., Gibson, M., et al. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01215-1 · Cited by 13
Cho, K., Kim, J. E., Komatsu, T., & Uehara, Y. (2023) · Life · doi:10.3390/life13061319 · Cited by 13
Zhao, X., Yuan, Y., Lin, Y., Zhang, T., Bai, Y., Kang, D., Li, X., Kang, W., Dlodlo, R. A., & Harries, A. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206372 · Cited by 21
Bächle, C., Scherler, W., Lang, A., Filla, T., & Kuß, O. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01887-y · Cited by 12
Malglycemia in the critical care setting. Part II: Relative and absolute hypoglycemia
Roberts, G., Krinsley, J. S., Preiser, J., Quinn, S. J., Rule, P. R., Brownlee, M., Umpierrez, G. E., & Hirsch, I. B. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154429 · Cited by 13
Choe, H., Sung, H., Kim, G., Lee, O., Moon, H. Y., & Kim, Y. S. (2021) · Epidemiology and Health · doi:10.4178/epih.e2021080 · Cited by 12
Zawiejska, A., Wróblewska‐Seniuk, K., Gutaj, P., Kippen, J., Gomulska, A., & Wender-Ożegowska, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071777 · Cited by 12
Jonusas, J., Aleknavičius, K., & Valinskas, S. (2023) · Smart Health · doi:10.1016/j.smhl.2023.100404 · Cited by 13
Orozco‐Beltrán, D., Navarro-Pérez, J., Cuenca, A. M. C., Guisasola, F. Á., Caride-Miana, E., Navarro, G. M., Quesada, J. A., López‐Pineda, A., Cardona-Llorens, A. F. J., Redón, J., et al. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.06.003 · Cited by 12
Martin, M., Patterson, J., Allison, M., O’Connor, B. B., & Patel, D. K. (2021) · JMIR Diabetes · doi:10.2196/24981 · Cited by 14
Lan, J., Yan, W., Zhu, Y., Zhang, Y., Zhang, S., Mo, L., Wei, D., & Lei, Y. (2023) · Surgical Infections · doi:10.1089/sur.2023.130 · Cited by 11
The Fruit and Veggies for Kidney Health Study: A Prospective Randomized Trial
Kitzman, H. E., Montgomery, A. H., Khan, M., Mamun, A. A., Tecson, K. M., Allison, P., Simoni, J., & Wesson, D. E. (2023) · Kidney Medicine · doi:10.1016/j.xkme.2023.100736 · Cited by 12
Aga, F., Dunbar, S. B., Kebede, T., Higgins, M. K., & GARY, R. A. (2020) · Nursing Open · doi:10.1002/nop2.517 · Cited by 14
Hyperglycemia, symptoms, and symptom clusters in colorectal cancer survivors with type 2 diabetes
Storey, S., Luo, X., Ofner, S., Perkins, S. M., & Ah, D. M. V. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07442-3 · Cited by 11
Gourdy, P., Bahloul, A., Boultif, Z., Gouet, D., & Guerci, B. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00734-8 · Cited by 11
Baumert, J. J., Heidemann, C., Paprott, R., Du, Y., & Scheidt‐Nave, C. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0319-2 · Cited by 11
Zolper, E. G., Deldar, R., Haffner, Z. K., Sayyed, A. A., Meshkin, D. H., Hill, C. B., Bekeny, J. C., Fan, K. L., Evans, K. K., & Attinger, C. E. (2022) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000247 · Cited by 10
Sugimoto, T., Sakurai, T., Uchida, K., Kuroda, Y., Tokuda, H., Omura, T., Noguchi, T., Komatsu, A., Nakagawa, T., Fujita, K., et al. (2024) · Diabetes Care · doi:10.2337/dc23-2324 · Cited by 10
Pantanetti, P., Ronconi, V., Sguanci, M. E., Palomares, S. M., Mancin, S., Tartaglia, F. C., Cangelosi, G., & Petrelli, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164752 · Cited by 11
Zeng, R., Zhang, Y., Xu, J., Kong, Y.-J., Tan, J.-W., Guo, L., & Zhang, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072615 · Cited by 12
Kim, K., Unni, S. K., Brixner, D. I., Thomas, S. M., Olsen, C. J., Sterling, K. L., Mitchell, M., & McAdam‐Marx, C. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13694 · Cited by 10
Metadata
- Authors
- Cavero-Redondo, I., Peleteiro, B., Álvarez-Bueno, C., Rodriguez-Artalejo, F., & Martínez-Vizcaíno, V.
- Affiliations
- Universidad de Castilla—La Mancha, Health and Social Research Center, Cuenca, Spain
- EPI Unit, Instituto de Saúde Pública,Universidade do Porto, Porto, Portugal
- Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid/ IdiPaz, CIBERESP, and IMDEA-Food Institute. CEI UAM+CSIC, Madrid, Spain
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-07
- Volume
- 7
- Issue
- 7
- Pages
- e015949
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC5642750
- OpenAlex
- W2739699420
- Cited by
- 260
- References
- 46
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 27 · 2023: 46 · 2022: 45 · 2021: 44 · 2020: 26 · 2019: 24 · 2018: 8 · 2017: 1
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- HighWire Press Open Archive (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Universidad de Castilla-La Mancha (FPU13/01582, FPU13/03137)
- Fundação para a Ciência e a Tecnologia (SFRH/BPD/108751/2015)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glycated haemoglobin A1c, HbA1c targets, all-cause mortality, cardiovascular mortality, cardiovascular events, diabetes mellitus, glycemic control, cardiovascular risk factors, non-diabetic population, HbA1c thresholds, cardiovascular disease prevention
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Risk Factors, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
